Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept

Annals of the Rheumatic Diseases

Volumn 69, Issue 6, 2010, Pages 1117-1122

  Lisbona, M Pilar ^a   Maymó, Joan ^a   Perich, Javier ^b   Almirall, Miriam ^a   Carbonell, Jordi ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GADOLINIUM;

ADULT; ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FINGER; FUNCTIONAL ASSESSMENT; HUMAN; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SYNOVITIS; TENDON SHEATH; TENOSYNOVITIS; WRIST;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; FINGER JOINT; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TENOSYNOVITIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WRIST JOINT;

EID: 77953709705     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.116277     Document Type: Article

References (31)

1. Zheng S, Robinson E, Yeoman S, et al. MRI bone oedema predicts eight year tendon function at the wrist but not the requirement for orthopaedic surgery in rheumatoid arthritis. Ann Rheum Dis 2006;65:607-11.
2. McQueen FM, Stewart N, Crabbe J, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998;57:350-6. (Pubitemid 28378310)
3. Valeri G, Ferrara C, Ercolani P, et al. Tendon involvement in rheumatoid arthritis of the wrist: MRI findings. Skeletal Radiol 2001;30:138-43.
4. Ostergaard M, McQueen FM, Bird P, et al. Magnetic resonance imaging in rheumatoid arthritis advances and research priorities. J Rheumatol 2005;32:2462-4.
5. Haavardsholm EA, Østergaard M, Ejbjerg BJ, et al. Introduction of a novel magnetic resonance imaging tenosynovitis score for rheumatoid arthritis: reliability in a multireader longitudinal study. Ann Rheum Dis 2007;66:1216-20.
6. Lisbona MP, Maymo J, Perich J, et al. Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks. J Rheumatol 2008;35:394-7.
7. Quinn MA, Conaghan PG, O'Connor PJ, et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:27-35.
8. Durez P, Malghem J, Nzeusseu Toukap A, et al. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Arthritis Rheum 2007;56:3919-27.
9. Haavardsholm EA, Uhlig T, Lilleas FG, et al. Anti-TNF-alpha treatment In rheumatoid arthritis (RA) reduces tenosynovitis evaluated by MRI. Ann Rheum Dis 2004;63:S297.
10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Rodríguez-Valverde V, Cáliz Cáliz R, Álvaro-Gracia Álvaro JM, et al. III Actualización del Consenso de la Sociedad Española de Reumatología sobre la terapia biológica en la artritis reumatoide. Reumatol Clin 2006;2(Suppl 2):P52-9.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
13. Cohen J. Statisitical power analysis for the behavioural sciences. 2nd edn. New Jersey, USA: Lawrence Erlbaum Associates Inc, 1988.
14. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
15. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
16. Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 1999;130:478-86.
17. Døhn UM, Skjødt H, Hetland ML, et al. No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammation. Clin Rheumatol 2007;26:1857-61.
18. Argyropoulou MI, Glatzouni A, Voulgari PV, et al. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with infliximab. Joint Bone Spine 2005;72:557-61.
19. Zikou AK, Argyropoulou MI, Voulgari PV, et al. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab. J Rheumatol 2006;33:219-23.
20. Boutry N, Lardé A, Lapègue F, et al. Magnetic resonance imaging appearance of the hands and feet in patients with early rheumatoid arthritis. J Rheumatol 2003;30:671-9. (Pubitemid 36402757)
21. Boutry N, Flipo RM, Cotten A. MR imaging appearance of rheumatoid arthritis in the foot. Semin Musculoskelet Radiol 2005;9:199-209. (Pubitemid 41362334)
22. Klarlund M, Ostergaard M, Jensen KE, et al. Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. The TIRA Group. Ann Rheum Dis 2000;59:521-8.
23. Maillefert JF, Dardel P, Cherasse A, et al. Magnetic resonance imaging in the assessment of synovial inflammation of the hindfoot in patients with rheumatoid arthritis and other polyarthritis. Eur J Radiol 2003;47:1-5.
24. McQueen F, Beckley V, Crabbe J, et al. Magnetic resonance imaging evidence of tendinopathy in early rheumatoid arthritis predicts tendon rupture at six years. Arthritis Rheum 2005;52:744-51.
25. Ryu J, Saito S, Honda T, et al. Risk factors and prophylactic tenosynovectomy for extensor tendon ruptures in the rheumatoid hand. J Hand Surg Br 1998;23:658-61.
26. Tolat AR, Stanley JK, Evans RA. Flexor tenosynovectomy and tenolysis in longstanding rheumatoid arthritis. J Hand Surg Br 1996;21:538-43.
27. Wheen DJ, Tonkin MA, Green J, et al. Long-term results following digital flexor tenosynovectomy in rheumatoid arthritis. J Hand Surg Am 1995;20:790-4.
28. Rubens DJ, Blebea JS, Totterman SM, et al. Rheumatoid arthritis: evaluation of wrist extensor tendons with clinical examination versus MR imaging - a preliminary report. Radiology 1993;187:831-8.
29. Haavardsholm EA, Østergaard M, Hammer HB, et al. Monitoring anti-TNF alpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist compared with conventional measures of disease activity and structural damage. Ann Rheum Dis 2009;68:1572-9.
30. Voulgari PV, Alamanos Y, Drosos AA. Persistent clinical response of infliximab therapy in patients with refractory rheumatoid arthritis, over a 3-year period. Curr Clin Pharmacol 2006;1:103-8.
31. Tam LS, Griffith JF, Yu AB, et al. Rapid improvement in rheumatoid arthritis patients on combination of methotrexate and infliximab: clinical and magnetic resonance imaging evaluation. Clin Rheumatol 2007;26:941-6.